RNA-Based Therapeutics: Targeting RNU4-62P for Cancer and DNA Damage Repair

Target Name: RNU4-62P

NCBI ID: G106479586

Other Name(s): RNA, U4 small nuclear 62, pseudogene

RNA-Based Therapeutics: Targeting RNU4-62P for Cancer and DNA Damage Repair

RNA, U4 small nuclear 62 (RNU4-62P), is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a small RNA molecule, with a length of approximately 200 nucleotides, and a typical exonuclease activity domain. RNU4-62P is expressed in all cell types and is highly conserved across different species.

RNU4-62P has been shown to play a critical role in various cellular processes, including DNA replication, gene expression, and DNA damage repair. It is a key regulator of the DNA double helix, and is involved in the regulation of DNA replication, transcription, and post-transcriptional modifications.

One of the unique features of RNU4-62P is its pseudogene nature. Pseudogenes are non-coding RNA molecules that have the potential to encode for proteins.RNU4-62P is a pseudogene that has been shown to encode for a protein with a predicted molecular weight of approximately 41 kDa. This protein is highly conserved and has been shown to have multiple functions, including regulating DNA replication, gene expression, and DNA damage repair.

In addition to its role in regulating DNA replication and repair, RNU4-62P is also involved in the regulation of gene expression. It has been shown to interact with various transcription factors, including T-DNA, and has been shown to play a role in the regulation of gene expression in various cell types.

RNU4-62P has also been shown to be involved in the regulation of DNA damage repair. Damage to the DNA double helix can lead to the development of various diseases, including cancer. RNU4-62P has been shown to play a role in the regulation of DNA damage repair, by helping to ensure that damaged DNA is properly repaired and that gene expression is not altered.

Due to its involvement in various cellular processes, RNU4-62P has been identified as a potential drug target. By targeting RNU4-62P, researchers hope to gain insights into the mechanisms of its function and the regulation of its various cellular processes.

In addition to its potential as a drug target, RNU4-62P has also been shown to be a potential biomarker. Its pseudogene nature and involvement in various cellular processes make it an attractive candidate for use as a diagnostic marker or therapeutic target.

Overall, RNU4-62P is a fascinating molecule that has the potential to be a drug target and biomarker. Further research is needed to fully understand its mechanisms of function and its potential as a therapeutic agent.

Protein Name: RNA, U4 Small Nuclear 62, Pseudogene

More Common Targets